Search
Ervogastat
go.drugbank.com/drugs/DB21489ExperimentalErvogastat is a small molecule drug. Ervogastat has a monoisotopic molecular weight of 407.16 Da.
Amelenodor
go.drugbank.com/drugs/DB21563ExperimentalAmelenodor is a small molecule drug. Amelenodor has a monoisotopic molecular weight of 399.16 Da.
Vulolisib
go.drugbank.com/drugs/DB21567ExperimentalVulolisib is a small molecule drug. Vulolisib has a monoisotopic molecular weight of 423.12 Da.
Teprosulvose
go.drugbank.com/drugs/DB21738ExperimentalTeprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.
Suvadronabinol
go.drugbank.com/drugs/DB21741ExperimentalSuvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.
Bermekimab
go.drugbank.com/drugs/DB14947InvestigationalBermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
Synonyms: RA-18C3CH-1504 L-isomer
go.drugbank.com/drugs/DB19052InvestigationalCH-1504 L-isomer is under investigation in clinical trial NCT01116141 (A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)).
Synonyms: L-m-trex, L-mobiletrexEtanercept
go.drugbank.com/drugs/DB00005ApprovedInvestigationalIt is used to treat or manage a variety of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis (AS), and juvenile idiopathic poly-articular arthritis (JIA). … Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids.
Products: Enbrel Solution for Injection in a Pre-filled Pen 50mg, Enbrel Solution for Injection in a Pre-filled Syringe 50mgAleglitazar
go.drugbank.com/drugs/DB08915InvestigationalAleglitazar is an investigational drug from the company Hoffmann–La Roche and is currently in a phase III clinical trial called ALECARDIO. … In the phase II clinical trial called SYNCHRONY, with type II diabetic patients, aleglitazar was able to control both lipid and glucose levels in a synergistic manner while also having limited side effects